An additional mechanism, albeit described in a murine model of tumorigenesis, by which systemic MDSCs interfere with distant anti-tumor immune mechanisms, is achieved via decreased expression of the lymph node homing receptor, L-selectin, on naïve T and B cells [109]. This evidence concerns the gene SELL and neoplasm.